Current Federal Drug Administration regulations require a generic drug’s labeling to be the same as its brand-name counterpart. Brand-name drug manufacturers are able to update product labels with new ...
Digoxin recalled over mislabeling Two lots of Digoxin were mislabeled, leading to a recall. Digoxin is used for the treatment of mild to moderate heart failure in children and adults. The Food and ...
MedPage Today on MSN
FDA says to drop suicide warning from GLP-1 drug labels
Concerns about GLP-1 drugs indicated for weight loss were first raised after the FDA's Adverse Event Reporting System ...
The U.S. Food and Drug Administration (FDA) published new draft guidance on “Regulatory Considerations for Prescription Drug Use-Related Software” (PDS Guidance), which describes how FDA intends to ...
Medications once used to treat illness are increasingly being taken for prevention. Experts explain what’s behind the ...
Recently, the California Board of Pharmacy announced changes to its drug labeling rules that will take effect on April 1, 2017. The Board of Pharmacy amended Section 1744 of Article 5 of Division 17 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback